Nov
2026
IICC, Yashobhoomi, Dwarka, Delhi
Visit us
stand 2G07

A R Life sciences Pvt Ltd

Exhibitor at CPHI India 2026
  • Country/Region:
    India
  • On CPHI since:
    2023
Contact info
  • No 1C, 4th Floor, Jyothi Imperial, Janardana Hills, Gachibowli, Hyderabad, India
Event information
CPHI India 2026
  • 23 Nov 2026 - 25 Nov 2026
  • IICC, Yashobhoomi, Dwarka, Delhi
  • Visit us at stand 2G07

Products Featured at CPHI India 2026

  • Abemaciclib  Intermediates

    Product Abemaciclib Intermediates

    1231930-33-8 and  1180132-17-5
  • Alogliptin and Linagliptin intermediates

    Product Alogliptin and Linagliptin intermediates

    (R)-3-Amino-piperidine dihydrochloride /// (R)-3-(Boc-Amino)piperidine  
  • Dabigatran intermediates

    Product Dabigatran intermediates

    Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate /// 2-(4-Cyanophenylamino) Acetic Acid
  • Etrasimod  Intermediates

    Product Etrasimod Intermediates

     Manufacturing Intermediates of  Cas No. 1206124-13-1 and 957208-65-0
  • Mirabegron Intermediates

    Product Mirabegron Intermediates

    2-(4-nitrophenyl)ethanamine hydrochloride // 2-(2-Aminothiazol-4-yl)acetic acid// R)-2-(4-nitrophenethylamino)-1- Phenylethanol // (R)-2-(4-aminophenethylamino)-1-Phenylethanol HCL

A R Life sciences Pvt Ltd Resources (1)

  • Brochure Product list

    A.R. Life sciences ( ARL) is a manufacturer of Bulk Drugs / API’s and Intermediates.  The company was established in the year 2007, head office located in Hyderabad, India. Company has an experienced and strong team of 200 + employees with strong client relationships with both International and domestic.  ARL has three manufacturing facilities, two located in Hyderabad (One facility USFDA approved) and a brand new facility commencing shortly in Vizag.  Infrastructure spread over  10 acres with reactor volume of ~136,000 liters (extendable upto 500,000 liters when fully occupied). Facilities are certified with ISO 9001-2015 and WHO GMP and the company follows cGLP and cGMP practices. In a very short span of time the company has grown into a vertically integrated company specializing in Intermediates and API’s covering various therapeutic areas.